我院对29例失代偿性肝炎后肝硬化腹水患者在利尿治疗中加用巯甲丙脯酸(Cap)治疗,加快了腹水消退进程,取得较好疗效,现报道如下。对象与方法病例选择将确诊的肝炎后肝硬化中重度腹水患者随机分为 Cap 组和对照组,Cap 组29例(男10例,女19例),年龄20～63岁,平均43.7岁,病程1～5年,平均2.3年;对照组33例(男15例,女18例),年龄23～56岁,平均41岁,病程1～4年,平均2.4年。两组平均病程、年龄、肝功能损害程度(转氨 Our hospital on 29 cases of decompensated cirrhosis patients with liver cirrhosis ascites in the diuretic treatment with captopril (Cap) treatment, to speed up the process of ascites extinction, and achieved good results, are reported below. Patients and Methods Case Selection Severe ascites patients with posthepatitic cirrhosis were randomly divided into Cap group and control group. There were 29 patients (10 males and 19 females) in Cap group, ranging in age from 20 to 63 years with an average of 43.7 years 1 to 5 years, an average of 2.3 years; control group of 33 patients (15 males and 18 females), aged 23 to 56 years, mean 41 years, duration of 1 to 4 years, an average of 2.4 years. Two groups of average duration, age, degree of liver damage (transaminase